Lentivirus: A Vector for Nervous System Applications

  • S. M. Kingsman
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 43)


Vectors based on lentiviruses are opening up new approaches for the treatment of neurological disease and damage. They efficiently deliver genes into many different types of primary neurons from a broad range of species including human, and the resulting gene expression is longterm and non-toxic. Numerous animal studies have now been undertaken with these vectors, and correction of disease models has been obtained. These vectors have been refined to a very high level, and they are now ready for clinical evaluation (reviewed in Martin-Rendon et al. 2001; Deglon and Aebischer 2002). This review will describe the general features of lentiviral vectors with particular emphasis on vectors derived from the non-primate lentivirus, equine infectious anaemia virus (EIAV), then give some key examples of gene transfer and genetic correction in animal models of neurological diseases. The prospects for the clinical evaluation of lentiviral vectors for the treatment of human neurological disease will be outlined.


Human Immunodeficiency Virus Motor Neuron Dorsal Root Ganglion Long Terminal Repeat Motor Neuron Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Azzouz M, Martin-Rendon E, Barber RD et al (2002) Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson’s disease. J Neuro 22: 10302–10312Google Scholar
  2. Brooks AI, Stein CS, Hughes SM et al (2002) Functional correction of established central nervous system deficits in an animal model of lysomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci USA 99: 6216–6221PubMedCrossRefGoogle Scholar
  3. Chavany C, Jendoubi M (1998) Biology and potential strategies for the treatment of GM2 gangliosidoses. Mol Med Today 4: 158–165PubMedCrossRefGoogle Scholar
  4. Cisterni C, Henderson CE, Aebischer P et al (2000) Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motor neurons transduced with lentiviral vectors. J Neurochem 74: 1820–1828PubMedCrossRefGoogle Scholar
  5. Corcoran J, So P-L, Barber RD, et al (2002) Retinoic acid receptor-I32 and neurite outgrowth in the adult mouse spinal cord. J Cell Sci 115: 3779–3786PubMedCrossRefGoogle Scholar
  6. de Almeida LP, Ross CA, Zala D et al (2002) Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci 22: 3473–3483PubMedGoogle Scholar
  7. Deglon N, Aebischer P (2002) Lentiviruses as vectors for CNS diseases. Curr Top Microbiol Immunol 261: 191–209PubMedCrossRefGoogle Scholar
  8. Desmaris N, Bosch A, Salvan C et al (2001) Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol Ther 4: 149–156PubMedCrossRefGoogle Scholar
  9. Fleming J, Ginn SL, Weinberger RP et al (2001) Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons. Hum Gene Ther 12: 77–86PubMedCrossRefGoogle Scholar
  10. Gurney M, Pu H, Chiu AY et al (1994) Motor neuron degeneration in mice that express a human Cu,ZN superoxide dismutase mutation. Science 264: 1772–1775PubMedCrossRefGoogle Scholar
  11. Han JJ, Mhatre AN, Wareing M et al (1999) Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Hum Gene Ther 10: 1867–1873PubMedCrossRefGoogle Scholar
  12. Hottinger AF, Azzouz M, Deglon N et al (2000) Complete and long-term rescue of lesioned adult motor neurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J Neurosci 20: 5587–5593PubMedGoogle Scholar
  13. Johnston JC, Gasmi M, Lim LE et al (1999) Minimum requirement for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 73: 4991–5000PubMedGoogle Scholar
  14. Kafri T, Van Praag H, Ouyang L et al (1999) A packaging cell line for lentivirus vectors. J Virol 73: 576–584PubMedGoogle Scholar
  15. Kang Y, Stein CS, Heth JA et al (2002) In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River virus glycoproteins. J Virol 76: 9378–9388PubMedCrossRefGoogle Scholar
  16. Kim VN, Mitrophanous K, Kingsman SM et al (1998) Minimal requirement for a lentivirus vector based on human immunodeficiency virus type J Virol 72: 811–816Google Scholar
  17. Kobinger GP, Weiner DJ, Yu QC et al (2001) Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol 19: 225–230PubMedCrossRefGoogle Scholar
  18. Kordower JH, Emborg ME, Bloch J et al (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290: 767–773PubMedCrossRefGoogle Scholar
  19. Kotsopoulou E, Kim VN, Kingsman AJK et al (2000) A rev-independent human immunodeficiency virus type-1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag/pol gene. J Virol 74: 4839–4852PubMedCrossRefGoogle Scholar
  20. Lewis P, Hensel M, Emerman N et al (1992) Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 11: 3053–3058PubMedGoogle Scholar
  21. Lo Bianco C, Ridet JL, Schneider BL et al (2002) a-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson’s disease. Proc Natl Acad Sci USA 99: 10813–10818Google Scholar
  22. Martin-Rendon E, White LJ, Olsen A et al (2002) New methods for titering EIAV lentiviral vectors. Mol Ther 5: 566–570PubMedCrossRefGoogle Scholar
  23. Martin-Rendon E, Azzouz M, Mazarakis ND et al (2001) Lentiviral vectors for the treatment of neurodegenerative diseases. Cuff Opin Mol Ther 3: 476–481CrossRefGoogle Scholar
  24. Mazarakis ND, Azzouz M, Rohll JB et al (2001) Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 10: 2109–2121PubMedCrossRefGoogle Scholar
  25. Miller AD (1997) Development and applications of retroviral vectors. In Coffin JM, Hughes SH, Varmus HE (eds) Retroviruses. Cold Spring Harbor Press, New York, pp 437–473Google Scholar
  26. Mitrophanous K, Yoon S, Rohll J et al (1999) Stable gene transfer to the nervous system using a nonprimate lentiviral vector. Gene Ther 6: 1808–1818PubMedCrossRefGoogle Scholar
  27. Miyoshi H, Blomer U, Takahashi M et al (1998) Development of a self-inactivating lentivirus vector. J Virol 72: 8150–8157PubMedGoogle Scholar
  28. Monani UR, Coovert DD, Burghes AH et al (2000) Animal models of spinal muscular atrophy. Hum Mol Gen 9: 2451–2457PubMedCrossRefGoogle Scholar
  29. Naldini L, Blomer U, Gallay P et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263–267PubMedCrossRefGoogle Scholar
  30. Olsen JC (1998) Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 5: 1481–1487PubMedCrossRefGoogle Scholar
  31. Otto E, Jones-Trower A, Vanin EF et al (1994) Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J Virol 68: 4241–4250Google Scholar
  32. Palfi S, Leventhal L, Chu Y et al (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 22: 4942–4954PubMedGoogle Scholar
  33. Patel CA, Mukhtar M, Harley S et al (2002) Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons. J Neurovirol 2: 86–99CrossRefGoogle Scholar
  34. Pfeifer A, Brandon EP, Kootstra N et al (2001) Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci USA 98: 11450–11455PubMedCrossRefGoogle Scholar
  35. Poeschla EM, Wong-Staal F, Looney DJ et al (1998) Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4: 354–357PubMedCrossRefGoogle Scholar
  36. Powell JS et al (2001) Phase I trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous injection. Thromb Haemost 86:0C2489Google Scholar
  37. Reiser J (2000) Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 7: 910–913PubMedCrossRefGoogle Scholar
  38. Rohl JB et al (2002) The design, production, safety, evaluation and clinical applications of nonprimate lentiviral vectors. Methods Enzymol 346: 466–500CrossRefGoogle Scholar
  39. Rojas M, Donahue JP Tan Z et al (1998) Genetic engineering of proteins with cell membrane permeability. Nat Biotechnol 16: 370–375PubMedCrossRefGoogle Scholar
  40. Sinnayah P, Lindley TE, Staber PD et al (2002) Selective gene transfer to key cardiovascular regions of the brain: comparison of two viral vector systems. Hypertension 39: 603–608PubMedCrossRefGoogle Scholar
  41. Stitz J, Buchholz CJ, Engelstadter M et al (2000) Lentiviral vectors pseudo-typed with envelope glycoprotein derived from gibbon ape leukaemia virus and murine leukaemia virus 10A1. Virology 273: 16–20PubMedCrossRefGoogle Scholar
  42. Stitz J, Muhlebach MD, Blomer U et al (2001) A novel lentivirus vector derived from apathogenic simian immunodeficiency virus. Virology 291: 191–197PubMedCrossRefGoogle Scholar
  43. Takahashi M, Miyoshi H, Verma IM et al (1999) Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Viro! 73: 7812–7816PubMedGoogle Scholar
  44. Trono D (1998) When accessories turn out to be essential. Nat Med 4: 1368–1369PubMedCrossRefGoogle Scholar
  45. Trono D (2000) Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther 7: 20–23PubMedCrossRefGoogle Scholar
  46. Watson DJ, Kobinger GP, Passini MA et al (2002) Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 5: 528–537Google Scholar
  47. Weber E, Anderson WF, Kasahara N et al (2001) Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks. Curr Opin Mol Ther 5: 439–453Google Scholar
  48. Xia H, Mao O, Davidson BL et al (2001) The HIV Tat protein transduction domain improves the biodistribution of 13-glucuronidase expressed from recombinant viral vectors. Nat Biotech 19: 640–644CrossRefGoogle Scholar
  49. Xu K, Ma H, McCown TJ et al (2001) Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther 1: 97–104CrossRefGoogle Scholar
  50. Zennou V, Serguero C, Sarkis C et al (2001) The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol 19: 446–450PubMedCrossRefGoogle Scholar
  51. Zufferey R, Dull T, Mandel RJ et al (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873–9880PubMedGoogle Scholar
  52. Zufferey R, Donello JE, Trono D et al (1999) Woodchuck hepatitis virus post-transcriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886–2892PubMedGoogle Scholar

Note added in press

  1. Bienemann AS, Martin-Rendon E, Cosgrave AS et al. (2003) Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin. Mol Ther 7: 588–596PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • S. M. Kingsman

There are no affiliations available

Personalised recommendations